Trial intelligence / Profile preview

Letrozole for pregnancy induction in women with polycystic ovary syndrome

IRCT20081007001306N12Phase 3Completed

Sponsor
Guilan University of Medical Sciences
Start
Jun 2024
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of letrozole in female infertility and polycystic ovary syndrome (PCOS), sponsored by Guilan University of Medical Sciences. Primary endpoint: Pregnancy rate. Started Jun 2024; status: completed.

02

Drugs

letrozole
03

Conditions

female infertilitypolycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on IRCT20081007001306N12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20081007001306N12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call